Laparoscopic retroperitoneal lymph-node dissection in the management of clinical stage I and II testicular cancer

Journal of Endourology

Volumn 19, Issue 6, 2005, Pages 683-692

  Albqami, Nasser ^a   Janetschek, Günter ^a,b  

^a ELISABETHINEN HOSPITAL   (Austria)

^b UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BLEEDING; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER RELAPSE; CANCER STAGING; DIAGNOSTIC ACCURACY; FOLLOW UP; HOSPITALIZATION; HUMAN; LAPAROSCOPIC SURGERY; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; OPERATION DURATION; PARAAORTIC LYMPH NODE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; TESTIS CANCER;

ADOLESCENT; ADULT; COHORT STUDIES; FOLLOW-UP STUDIES; HUMANS; LAPAROSCOPY; LYMPH NODE EXCISION; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; ORCHIECTOMY; RETROPERITONEAL SPACE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURGICAL PROCEDURES, MINIMALLY INVASIVE; SURVIVAL ANALYSIS; TESTICULAR NEOPLASMS; TREATMENT OUTCOME;

EID: 23744480579     PISSN: 08927790     EISSN: None     Source Type: Journal    
DOI: 10.1089/end.2005.19.683     Document Type: Article

References (33)

1. Bosl GJ, Motzer RJ. Testicular germ-cell cancer. N Engl J Med 1997;337:242-253.
2. Bussar-Matz R, Weissbach L. Retroperitoneal lymph node staging of testicular tumours. TNM Study Group. Br J Urol 1993;72: 234-240.
3. Donohue JP, Thomhill JA, Foster RS, Roland RG, Bihrle R. Retroperitoneal lymphadenectomy for clinical stage A testis cancer (1965-1989): Modification of technique and impact on ejaculation. J Urol 1993;149:237-243.
4. Williams SD, Stablein DM, Einhorn LH, et al. Immediate adjuvant chemotherapy versus observation with treatment at relapse in pathological stage II testicular cancer. N Engl J Med 1987;317: 1433-1438.
5. Steiner H, Peschel R, Janetschek G, Hold L, Berger AP, Bartsch G, Hobisch A. Long-term result of laparoscopic retroperitoneal lymph node dissection: A single-center 10-year experience. Urology 2004;63:550-555.
6. Corvin S, Kuczyk M, Anastasiadis A, Stenzl A. Laparoscopic retroperitoneal lymph node dissection for nonseminomatous testicular carcinoma. World J Urol 2004;22:33-36.
7. Rassweiler JJ, Frede T, Lenz E, Seemann O, Alken P. Long-term experience with laparoscopic retroperitoneal lymph node dissection in the management of low-stage testis cancer. Eur Urol 2000; 37:251-260.
8. Bhayani SB, Allaf ME, Kavoussi LR. Laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell testicular cancer: Current status. Urol Oncol 2004;22:145-148.
9. Weissbach L, Boedefeld EA. Testicular Tumor Study Group: Localization of solitary and multiple metastases in stage II non seminomatous testis tumor as basis for modified staging lymph node dissection in stage I. J Urol 1987;138:77-82.
10. Holtl L, Peschel R, Knapp R, et al. Primary lymphatic metastatic spread in testicular cancer occurs ventral to the lumbar vessels. Urology 2002;59:114-118.
11. Janetschek G, Peschel R, Bartsch G. Laparoscopic retroperitoneal lymph node dissection. Atlas Urol Clin North Am 2000;8:71-90.
12. Roeleveld TA, Horenblas S, Meinhardt W. Surveillance can be the standard of care for stage I nonseminomatous testicular tumour and even high risk patients. J Urol 2001;166:2166-2170.
13. Laguna MP, Klepp O, Horwich A, Algaba F, Bokemeyer C, Pizzocaro G, Cohn-Cedemark G, Albers P. Guidelines on testicular cancer. Eur Assoc Urol Update March 2004.
14. Sogani PC, Perrotti M, Herr HW, Fair WR, Thaler HT, Bosl G. Clinical stage I testis cancer: Long-term outcome of patients on surveillance. J Urol 1998;159:855-858.
15. Nicolai R, Pizzocaro G. A surveillance study of clinical stage I non-seminomatous germ cell tumors of the testis: 1-year follow up. J Urol 1995;154:1045-1049.
16. Albers P, Siener R, Kliesch S, et al. Risk factors for relapse in clinical stage I nonseminomatous testicular germ cell tumors: Results of the German Testicular Cancer Group trial. J Clin Oncol 2003;21: 1505-1512.
17. Spermon JR, Roeleveld TA, van der Poel CA. Comparison of surveillance and retroperitoneal lymph node dissection in stage I nonseminomatous testicular germ cell tumors. Urology 2002;59: 923-929.
18. Richie JP, Kantoff PW. Is adjuvant chemotherapy necessary for patients with stage BI testicular cancer? J Clin Oncol 1991;9:1393-1396.
19. Javadpour N. Predictors of recurrence in stage II nonseminomatous testicular cancer after lymphadenectomy. Implications for adjuvant chemotherapy. J Urol 1984;135:629.
20. Castillo O, Urena R, Pinto I, Olivares R, Portalier P. Laparoscopic retroperitoneal lymph node dissection for stage I and II NSGCT [abstract 933], J Urol 2004;171(suppl):247-248.
21. Bhayani SB, Ong A, Oh WK, Kantoff PW, Kavoussi LR. Laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell testicular cancer: A long-term update. Urology 2003;62:324-327.
22. Le Blanc E, Caty A, Dargent D, Querleu D, Mazeman E. Extraperitoneal laparoscopic para-aortic lymph node dissection for early stage non seminomatous germ cell tumor of the testis with introduction of a nerve sparing technique description and results. J Urol 2001;165:89-92.
23. Janetschek G, Hobisch A, Höltl L, et al. Retroperitoneal lymphadenectomy for clinical stage I nonseminomatous testicular tumor: Laparoscopy versus open surgery and impact of learning curve. J Urol 1996;156:89-93.
24. Heidenreich A, Albers P, Hartmann M, Kliesch S, Koehrmann K, Krege S, Lossin P, Weissbach L. Complications of nerve sparing retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumours of the testis: Experience of the German Testicular Cancer Study Group. J Urol 2003;169:1710-1714.
25. Rassweiler J J, Seemann O, Henkel TO, Stock C, Frede T, Alken P. Laparoscopic retroperitoneal lymph node dissection for non seminomatous germ cell tumor: Indication and limitation. J Urol 1996;156:1108-1113.
26. Palese MA, Li-Ming Su, Kavoussi LR. Laparoscopic retroperitoneal lymph node dissection after chemotherapy. Urology 2002; 60:130-134.
27. Steiner H, Holtl L, Wirtenberger W, Berger AP, Bartsch G, Hobisch A. Long-term experience with carboplatin monotherapy for clinical stage I seminoma: A retrospective single-center study. Urology 2002;60:324-328.
28. Donohue JP, Foster RS, Rowland RG, et al. Nerve-sparing retroperitoneal lymphadenectomy with preservation of ejaculation. J Urol 1990;144:287-291.
29. Whitelaw GP, Smithwick RH. Some secondary effects of sympathectomy with particular reference to disturbance of sexual function. N Engl J Med 1951;245:212.
30. Peschel R, Gettman MT, Neururer R, Hobisch A, Bartsch G. Laparoscopic retroperitoneal lymph node dissection: Description of the nerve sparing technique. Urology 2002;60:339-343.
31. Janetschek G. Laparoscopic RPLND. Urol Clin North Am 2001; 28:107-114.
32. Ogan K, Lotan Y, Koeneman K, Pearle MS, Cadeddu JA, Rassweiler JJ. Laparoscopic versus open retroperitoneal lymph node dissection: A cost analysis. J Urol 2002;168:1945-1949.
33. Hobisch A, Tönnemann J, Janetschek G. Morbidity and quality of life after open versus laparoscopic retroperitoneal lymphadenectomy for testicular tumour: The patient's view. In: Jones WG, Appleyard 1, Harnden P, Joffe JK (eds): Germ Cell Tumours VI. London: John Libbey, 1998, p 277.